# PTH Analog Type II Odontoid Fracture

> **NCT04760782** · PHASE2 · TERMINATED · sponsor: **David Lunardini** · enrollment: 22 (actual)

## Conditions studied

- Odontoid Fracture

## Interventions

- **DRUG:** Abaloparatide
- **DEVICE:** Hard collar immobilization

## Key facts

- **NCT ID:** NCT04760782
- **Lead sponsor:** David Lunardini
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-18
- **Primary completion:** 2023-08-14
- **Final completion:** 2023-08-14
- **Target enrollment:** 22 (ACTUAL)
- **Why stopped:** Study terminated early due to low recruitment rate.
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04760782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04760782, "PTH Analog Type II Odontoid Fracture". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04760782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*